Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
Alzheimer’s drug Leqembi brought in in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.
-
Treasury yields rise as investors weigh economic outlook
U.S. Treasury yields rose on Wednesday as investors considered the latest economic data and weighed the state of the economy.
-
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
For the first time, some Medicare beneficiaries will be able to access Novo Nordisk’s Wegovy without having to shoulder the total monthly price tag.
-
UBS chair says Swiss banking giant is not ‘too big to fail'
Colm Kelleher also said UBS was one of the best-capitalized banks in Europe at the UBS Annual General Meeting.
-
NASA releases satellite photos of Dubai and Abu Dhabi before and after record flooding
The deluge closed schools and businesses, grounded hundreds of flights, and destroyed cars, businesses and other property.